{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:06:27Z","timestamp":1770350787725,"version":"3.49.0"},"reference-count":117,"publisher":"Bentham Science Publishers Ltd.","issue":"25","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Alzheimer's Disease (AD) is the most common cause of dementia, afflicting\nover 5 million people in the United States. There remains a lack of effective diseasemodifying\ntreatments for AD beyond a few approved drugs that provide temporary\nsymptomatic relief. Melatonin is an endogenous hormone mainly produced by the pineal\ngland that regulates circadian rhythms and possesses antioxidant and anti-inflammatory\nproperties. An expansive body of research over the past few decades has investigated\nmelatonin as a promising therapeutic agent for AD based on its ability to target multiple\npathophysiological processes implicated in AD progression. In this comprehensive review,\nwe summarize extensive evidence from cellular and animal models that has uncovered\nthe diverse mechanisms underpinning melatonin's neuroprotective efficacy against\nAD pathology. We also synthesize clinical studies examining melatonin's effects on AD\nprogression and symptoms. Additionally, we discuss how melatonin's multimodal mechanisms,\nfavorable safety profile, and ability to synergize with conventional therapies\nheighten its potential as an effective therapeutic strategy for AD. Rigorously designed\nclinical trials incorporating physiological biomarkers are warranted to definitively establish\nmelatonin's disease-modifying effects. Nevertheless, the considerable preclinical data\nsupport further exploration of melatonin as a therapeutic agent for AD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673286807240326085736","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T07:05:22Z","timestamp":1712991922000},"page":"5139-5154","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Therapeutic Potential of Melatonin in Alzheimer's Disease: A Comprehensive Review"],"prefix":"10.2174","volume":"32","author":[{"given":"Jialang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Spine Surgery, Honghui Hospital, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, 710054, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhe","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Spine Surgery, Honghui Hospital, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, 710054, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingbo","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Spine Surgery, Honghui Hospital, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, 710054, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Veitch D.P.","year":"2023","unstructured":"Veitch D.P.; Weiner M.W.; Miller M.; Aisen P.S.; Ashford M.A.; Beckett L.A.; Green R.C.; Harvey D.; Jack C.R.; Jagust W.; The Alzheimer\u2019s disease neuroimaging initiative in the era of Alzheimer\u2019s disease treatment: A review of ADNI studies from 2021 to 2022. Alzheimers Dement  2023","journal-title":"Alzheimers Dement"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000534400","volume":"32","author":"Pauwels E.K.J.","year":"2023","unstructured":"Pauwels E.K.J.; Boer G.J.; Friends and foes in Alzheimer\u2019s disease. Med Princ Pract  2023,32(6),313-322","journal-title":"Med Princ Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"102534","DOI":"10.1016\/j.pneurobio.2023.102534","volume":"231","author":"Liu W.","year":"2023","unstructured":"Liu W.; Li Y.; Zhao T.; Gong M.; Wang X.; Zhang Y.; Xu L.; Li W.; Li Y.; Jia J.; The role of N-methyl-D-aspartate glutamate receptors in Alzheimer\u2019s disease: From pathophysiology to therapeutic approaches. Prog Neurobiol  2023,231,102534","journal-title":"Prog Neurobiol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"Cummings J.","year":"2023","unstructured":"Cummings J.; Apostolova L.; Rabinovici G.D.; Atri A.; Aisen P.; Greenberg S.; Hendrix S.; Selkoe D.; Weiner M.; Petersen R.C.; Salloway S.; Lecanemab: Appropriate use recommendations. J Prev Alzheimers Dis  2023,10(3),362-377","journal-title":"J Prev Alzheimers Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.neubiorev.2021.04.034","volume":"127","author":"Sumsuzzman D.M.","year":"2021","unstructured":"Sumsuzzman D.M.; Choi J.; Jin Y.; Hong Y.; Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer\u2019s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials. Neurosci Biobehav Rev  2021,127,459-473","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/fcp.12955","volume":"38","author":"Golmohammadi M.","year":"2024","unstructured":"Golmohammadi M.; Mahmoudian M.; Hasan E.K.; Alshahrani S.H.; Romero-Parra R.M.; Malviya J.; Hjazi A.; Najm M.A.A.; Almulla A.F.; Zamanian M.Y.; Kadkhodaei M.; Neuroprotective effects of riluzole in Alzheimer\u2019s disease: A comprehensive review. Fundam Clin Pharmacol  2024,38(2),225-237","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s10571-023-01408-7","volume":"43","author":"Dave B.P.","year":"2023","unstructured":"Dave B.P.; Shah Y.B.; Maheshwari K.G.; Mansuri K.A.; Prajapati B.S.; Postwala H.I.; Chorawala M.R.; Pathophysiological aspects and therapeutic armamentarium of Alzheimer\u2019s disease: Recent trends and future development. Cell Mol Neurobiol  2023,43(8),3847-3884","journal-title":"Cell Mol Neurobiol"},{"key":"ref=8","author":"Zhang M.","year":"2023","unstructured":"Zhang M.; Qian X.H.; Hu J.; Zhang Y.; Lin X.; Hai W.; Shi K.; Jiang X.; Li Y.; Tang H.D.; Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-beta deposition in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imag  2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1038\/s41467-023-41545-7","volume":"14","author":"Maniv I.","year":"2023","unstructured":"Maniv I.; Sarji M.; Bdarneh A.; Feldman A.; Ankawa R.; Koren E.; Magid-Gold I.; Reis N.; Soteriou D.; Salomon-Zimri S.; Lavy T.; Kesselman E.; Koifman N.; Kurz T.; Kleifeld O.; Michaelson D.; van Leeuwen F.W.; Verheijen B.M.; Fuchs Y.; Glickman M.H.; Altered ubiquitin signaling induces Alzheimer\u2019s disease-like hallmarks in a three-dimensional human neural cell culture model. Nat Commun  2023,14(1),5922","journal-title":"Nat Commun"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1249018","DOI":"10.3389\/fnut.2023.1249018","volume":"10","author":"Peng G.","year":"2023","unstructured":"Peng G.; Li M.; Meng Z.; Polysaccharides: Potential bioactive macromolecules for Alzheimer\u2019s disease. Front Nutr  2023,10,1249018","journal-title":"Front Nutr"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1523\/JNEUROSCI.0421-09.2009","volume":"29","author":"He P.","year":"2009","unstructured":"He P.; Shen Y.; Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer\u2019s disease. J Neurosci  2009,29(20),6545-6557","journal-title":"J Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1460-9568.2010.7483.x","volume":"33","author":"Zhang L.","year":"2011","unstructured":"Zhang L.; Yang X.; Yang S.; Zhang J.; The Wnt \/\u03b2- catenin signaling pathway in the adult neurogenesis. Eur J Neurosci  2011,33(1),1-8","journal-title":"Eur J Neurosci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jpi.12238","volume":"59","author":"Ali T.","year":"2015","unstructured":"Ali T.; Kim M.O.; Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via  3\/Akt\/  k3\u03b2 pathway in the mouse hippocampus. J Pineal Res  2015,59(1),47-59","journal-title":"J Pineal Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-230313","volume":"96","author":"Lardelli M.","year":"2023","unstructured":"Lardelli M.; An alternative view of familial Alzheimer\u2019s disease genetics. J Alzheimers Dis  2023,96(1),13-39","journal-title":"J Alzheimers Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"100814","DOI":"10.1016\/j.ortho.2023.100814","volume":"21","author":"Mohammadi I.","year":"2023","unstructured":"Mohammadi I.; Adibparsa M.; Najafi A.; Sehat M.S.; Sadeghi M.; A systematic review with meta-analysis to assess Alzheimer\u2019s disease biomarkers in adults with or without obstructive sleep apnoea. Int Orthod  2023,21(4),100814","journal-title":"Int Orthod"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"148565","DOI":"10.1016\/j.brainres.2023.148565","volume":"1821","author":"Yu H.","year":"2023","unstructured":"Yu H.; Morihara R.; Ota-Elliott R.; Bian Z.; Bian Y.; Hu X.; Sun H.; Fukui Y.; Abe K.; Ishiura H.; Yamashita T.; Injection of exogenous amyloid-\u03b2 oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice. Brain Res  2023,1821,148565","journal-title":"Brain Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1111\/jcmm.16325","volume":"25","author":"Bi J.","year":"2021","unstructured":"Bi J.; Shen J.; Chen C.; Li Z.; Tan H.; Sun P.; Lin Y.; Role of melatonin in the dynamics of acute spinal cord injury in rats. J Cell Mol Med  2021,25(6),2909-2917","journal-title":"J Cell Mol Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1051\/rnd:19990305","volume":"39","author":"Bernard M.","year":"1999","unstructured":"Bernard M.; Guerlott\u00e9 J.; Gr\u00e8ve P.; Gr\u00e9chez-Cassiau A.; Iuvone M.P.; Zatz M.; Chong N.W.; Klein D.C.; Voisin P.; Melatonin synthesis pathway: Circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retina. Reprod Nutr Dev  1999,39(3),325-334","journal-title":"Reprod Nutr Dev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.7150\/jca.85353","volume":"14","author":"Shi X.","year":"2023","unstructured":"Shi X.; Li H.; Dan Z.; Shu C.; Zhu R.; Yang Q.; Wang Y.; Zhu H.; Melatonin potentiates sensitivity to 5-fluorouracil in gastric cancer cells by upregulating autophagy and downregulating myosin light-chain kinase. J Cancer  2023,14(14),2608-2618","journal-title":"J Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1021\/jm401343c","volume":"57","author":"Zlotos D.P.","year":"2014","unstructured":"Zlotos D.P.; Jockers R.; Cecon E.; Rivara S.; Witt-Enderby P.A.; MT1 and MT2 melatonin receptors: Ligands, models, oligomers, and therapeutic potential. J Med Chem  2014,57(8),3161-3185","journal-title":"J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e19779","DOI":"10.1016\/j.heliyon.2023.e19779","volume":"9","author":"Sohail S.","year":"2023","unstructured":"Sohail S.; Shah F.A.; Zaman S.; Almari A.H.; Malik I.; Khan S.A.; Alamro A.A.; Zeb A.; Din F.; Melatonin delivered in solid lipid nanoparticles ameliorated its neuroprotective effects in cerebral ischemia. Heliyon  2023,9(9),e19779","journal-title":"Heliyon"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.1111\/jpi.12465","volume":"64","author":"Maria S.","year":"2018","unstructured":"Maria S.; Samsonraj R.M.; Munmun F.; Glas J.; Silvestros M.; Kotlarczyk M.P.; Rylands R.; Dudakovic A.; van Wijnen A.J.; Enderby L.T.; Lassila H.; Dodda B.; Davis V.L.; Balk J.; Burow M.; Bunnell B.A.; Witt-Enderby P.A.; Biological effects of melatonin on osteoblast\/osteoclast cocultures, bone, and quality of life: Implications of a role for  2 melatonin receptors,  1\/2, and  5 in melatonin-mediated osteoblastogenesis. J Pineal Res  2018,64(3),e12465","journal-title":"J Pineal Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"113357","DOI":"10.1016\/j.foodres.2023.113357","volume":"173","author":"Liu R.","year":"2023","unstructured":"Liu R.; Shang F.; Niu B.; Wu W.; Han Y.; Chen H.; Gao H.; Melatonin treatment delays the softening of blueberry fruit by modulating cuticular wax metabolism and reducing cell wall degradation. Food Res Int  2023,173(Pt 2),113357","journal-title":"Food Res Int"},{"key":"ref=24","first-page":"425","volume":"52","author":"Trivedi A.K.","year":"2014","unstructured":"Trivedi A.K.; Kumar V.; Melatonin: An internal signal for daily and seasonal timing. Indian J Exp Biol  2014,52(5),425-437","journal-title":"Indian J Exp Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-022-28111-3","volume":"13","author":"Wang Q.","year":"2022","unstructured":"Wang Q.; Lu Q.; Guo Q.; Teng M.; Gong Q.; Li X.; Du Y.; Liu Z.; Tao Y.; Structural basis of the ligand binding and signaling mechanism of melatonin receptors. Nat Commun  2022,13(1),454","journal-title":"Nat Commun"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2174\/1570159X17666190409144558","volume":"16","author":"Farf\u00e1n-Garc\u00eda E.D.","year":"2019","unstructured":"Farf\u00e1n-Garc\u00eda E.D.; M\u00e1rquez-G\u00f3mez R.; Barr\u00f3n- Gonz\u00e1lez M.; P\u00e9rez-Capistran T.; Rosales-Hern\u00e1ndez M.C.; Pinto-Almaz\u00e1n R.; Soriano-Urs\u00faa M.A.; Monoamines and their derivatives on GPCRs: Potential therapy for Alzheimer\u2019s disease. Curr Alzheimer Res  2019,16(10),871-894","journal-title":"Curr Alzheimer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"E7997","DOI":"10.1073\/pnas.1705768114","volume":"114","author":"Suofu Y.","year":"2017","unstructured":"Suofu Y.; Li W.; Jean-Alphonse F.G.; Jia J.; Khattar N.K.; Li J.; Baranov S.V.; Leronni D.; Mihalik A.C.; He Y.; Cecon E.; Wehbi V.L.; Kim J.; Heath B.E.; Baranova O.V.; Wang X.; Gable M.J.; Kretz E.S.; Di Benedetto G.; Lezon T.R.; Ferrando L.M.; Larkin T.M.; Sullivan M.; Yablonska S.; Wang J.; Minnigh M.B.; Guillaumet G.; Suzenet F.; Richardson R.M.; Poloyac S.M.; Stolz D.B.; Jockers R.; Witt-Enderby P.A.; Carlisle D.L.; Vilardaga J.P.; Friedlander R.M.; Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proc Natl Acad Sci USA  2017,114(38),E7997-E8006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fendo.2019.00087","volume":"10","author":"Gobbi G.","year":"2019","unstructured":"Gobbi G.; Comai S.; Differential function of melatonin MT and MT receptors in REM and NREM sleep. Front Endocrinol (Lausanne)  2019,10,87","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbr.2013.01.008","volume":"243","author":"Comai S.","year":"2013","unstructured":"Comai S.; Ochoa-Sanchez R.; Gobbi G.; Sleep-wake characterization of double MT1\/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice. Behav Brain Res  2013,243,231-238","journal-title":"Behav Brain Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S2352","DOI":"10.1016\/j.sleh.2023.08.017","author":"Cox R.C.","year":"2023","unstructured":"Cox R.C.; Blumenstein A.B.; Burke T.M.; Depner C.M.; Guerin M.K.; Hay-Arthur E.; Higgins J.; Knauer O.A.; Lanza S.M.; Markwald R.R.; Melanson E.L.; McHill A.W.; Morton S.J.; Ritchie H.K.; Smith M.R.; Smits A.N.; Sprecher K.E.; Stothard E.R.; Withrow D.; Wright K.P.; Distribution of dim light melatonin offset (DLMOff) and phase relationship to waketime in healthy adults and associations with chronotype. Sleep Health  2023,S2352","journal-title":"Sleep Health"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/07420528.2023.2262572","volume":"40","author":"Melloni E.M.T.","year":"2023","unstructured":"Melloni E.M.T.; Paolini M.; Dallaspezia S.; Lorenzi C.; Poletti S.; d\u2019Orsi G.; Yoshiike T.; Zanardi R.; Colombo C.; Benedetti F.; Melatonin secretion patterns are associated with cognitive vulnerability and brain structure in bipolar depression. Chronobiol Int  2023,40(9),1279-1290","journal-title":"Chronobiol Int"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jopan.2023.07.007","volume":"39","author":"Mori K.","year":"2024","unstructured":"Mori K.; Komatsu T.; Fujiwara Y.; Fujita Y.; Comparison of the effects of desflurane and sevoflurane on variations in salivary melatonin and sleep disturbance after total knee arthroplasty: A single-center, prospective, randomized, controlled, open-label study. J Perianesth Nurs  2024,39(1),101-108","journal-title":"J Perianesth Nurs"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2020.07.075","volume":"530","author":"Kobayashi-Sun J.","year":"2020","unstructured":"Kobayashi-Sun J.; Suzuki N.; Hattori A.; Yamaguchi M.; Kobayashi I.; Melatonin suppresses both osteoblast and osteoclast differentiation through repression of epidermal Erk signaling in the zebrafish scale. Biochem Biophys Res Commun  2020,530(4),644-650","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1515\/cclm-2023-0990","volume":"62","author":"Klafki H.W.","year":"2024","unstructured":"Klafki H.W.; Wirths O.; Jahn O.; Morgado B.; Esselmann H.; Wiltfang J.; Blood plasma biomarkers for Alzheimer\u2019s disease: A\u03b21-42\/1-40 vs. A\u03b2X-42\/X-40. Clin Chem Lab Med  2024,62(2),e56-e57","journal-title":"Clin Chem Lab Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"9464","DOI":"10.18632\/aging.205015","volume":"15","author":"Wang J.","year":"2023","unstructured":"Wang J.; Zhou F.; Xiong C.E.; Wang G.P.; Chen L.W.; Zhang Y.T.; Qi S.G.; Wang Z.H.; Mei C.; Xu Y.J.; Zhan J.B.; Cheng J.; Serum sirtuin1: A potential blood biomarker for early diagnosis of Alzheimer\u2019s disease. Aging (Albany NY)  2023,15(18),9464-9478","journal-title":"Aging (Albany NY)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.2174\/138161282035140911142118","volume":"20","author":"Valero T.","year":"2014","unstructured":"Valero T.; Mitochondrial biogenesis: Pharmacological approaches. Curr Pharm Des  2014,20(35),5507-5509","journal-title":"Curr Pharm Des"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"110735","DOI":"10.1016\/j.brainresbull.2023.110735","volume":"202","author":"Huang H.","year":"2023","unstructured":"Huang H.; Zhu Y.; Liao L.; Gao S.; Tao Y.; Fang X.; Lian Y.; Gao C.; The long-term effects of intermittent theta burst stimulation on Alzheimer\u2019s disease-type pathologies in APP\/PS1 mice. Brain Res Bull  2023,202,110735","journal-title":"Brain Res Bull"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/1570159X15666170313123454","volume":"15","author":"Shukla M.","year":"2017","unstructured":"Shukla M.; Govitrapong P.; Boontem P.; Reiter R.J.; Satayavivad J.; Mechanisms of melatonin in alleviating alzheimer\u2019s disease. Curr Neuropharmacol  2017,15(7),1010-1031","journal-title":"Curr Neuropharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-015-0027-6","volume":"10","author":"O\u2019Neal-Moffitt G.","year":"2015","unstructured":"O\u2019Neal-Moffitt G.; Delic V.; Bradshaw P.C.; Olcese J.; Prophylactic melatonin significantly reduces Alzheimer\u2019s neuropathology and associated cognitive deficits independent of antioxidant pathways in A\u03b2PPswe\/PS1 mice. Mol Neurodegener  2015,10(1),27","journal-title":"Mol Neurodegener"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e12902","DOI":"10.1111\/acel.12902","volume":"18","author":"Tang H.","year":"2019","unstructured":"Tang H.; Ma M.; Wu Y.; Deng M.F.; Hu F.; Almansoub H.; Huang H.Z.; Wang D.Q.; Zhou L.T.; Wei N.; Man H.; Lu Y.; Liu D.; Zhu L.Q.; Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer\u2019s disease via C\/EBP\u03b1\/miR-125b pathway. Aging Cell  2019,18(2),e12902","journal-title":"Aging Cell"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"115442","DOI":"10.1016\/j.biopha.2023.115442","volume":"167","author":"Zhang S.","year":"2023","unstructured":"Zhang S.; Liu F.; Li J.; Jing C.; Lu J.; Chen X.; Wang D.; Cao D.; Zhao D.; Sun L.; A 4.7-kDa polysaccharide from Panax ginseng suppresses A\u03b2 pathology via mitophagy activation in cross-species Alzheimer\u2019s disease models. Biomed Pharmacother  2023,167,115442","journal-title":"Biomed Pharmacother"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ddr.22113","volume":"84","author":"Singh Y.P.","year":"2023","unstructured":"Singh Y.P.; Kumar N.; Chauhan B.S.; Garg P.; Carbamate as a potential anti-Alzheimer\u2019s pharmacophore: A review. Drug Dev Res  2023,84(8),1624-1651","journal-title":"Drug Dev Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1007\/s11064-023-04005-8","volume":"48","author":"Pang L.W.","year":"2023","unstructured":"Pang L.W.; Hamzah S.; Tan S.L.J.; Mah S.H.; Yow H.Y.; The effects and mechanisms of xanthones in Alzheimer\u2019s disease: A systematic review. Neurochem Res  2023,48(12),3485-3511","journal-title":"Neurochem Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e0170607","DOI":"10.1371\/journal.pone.0170607","volume":"12","author":"Angelani C.R.","year":"2017","unstructured":"Angelani C.R.; Caramelo J.J.; Curto L.M.; Delfino J.M.; Structural coalescence underlies the aggregation propensity of a \u03b2-barrel protein motif. PLoS One  2017,12(2),e0170607","journal-title":"PLoS One"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1021\/bi052556a","volume":"45","author":"Mu\u00f1oz V.","year":"2006","unstructured":"Mu\u00f1oz V.; Ghirlando R.; Blanco F.J.; Jas G.S.; Hofrichter J.; Eaton W.A.; Folding and aggregation kinetics of a beta-hairpin. Biochemistry  2006,45(23),7023-7035","journal-title":"Biochemistry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.1021\/acsabm.0c00996","volume":"3","author":"Zheng Y.","year":"2020","unstructured":"Zheng Y.; Wang P.; Li S.; Geng X.; Zou L.; Jin M.; Zou Q.; Wang Q.; Yang X.; Wang K.; Development of DNA aptamer as a \u03b2-Amyloid aggregation inhibitor. ACS Appl Bio Mater  2020,3(12),8611-8618","journal-title":"ACS Appl Bio Mater"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/bip.20665","volume":"88","author":"Ignatova Z.","year":"2007","unstructured":"Ignatova Z.; Krishnan B.; Bombardier J.P.; Marcelino A.M.C.; Hong J.; Gierasch L.M.; From the test tube to the cell: Exploring the folding and aggregation of a \u03b2-clam protein. Biopolymers  2007,88(2),157-163","journal-title":"Biopolymers"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jb\/mvu039","volume":"156","author":"Mittal S.","year":"2014","unstructured":"Mittal S.; Singh L.R.; Macromolecular crowding decelerates aggregation of a \u03b2-rich protein, bovine carbonic anhydrase: A case study. J Biochem  2014,156(5),273-282","journal-title":"J Biochem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2174\/1567205015666180411092551","volume":"15","author":"Pappolla M.A.","year":"2018","unstructured":"Pappolla M.A.; Matsubara E.; Vidal R.; Pacheco-Quinto J.; Poeggeler B.; Zagorski M.; Sambamurti K.; Melatonin treatment enhances A\u03b2 lymphatic clearance in a transgenic mouse model of amyloidosis. Curr Alzheimer Res  2018,15(7),637-642","journal-title":"Curr Alzheimer Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"47863","DOI":"10.1074\/jbc.M104068200","volume":"276","author":"Hu J.","year":"2001","unstructured":"Hu J.; Igarashi A.; Kamata M.; Nakagawa H.; Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem  2001,276(51),47863-47868","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.colsurfb.2004.08.011","volume":"39","author":"Parkinson E.L.","year":"2004","unstructured":"Parkinson E.L.; Dickinson E.; Inhibition of heat-induced aggregation of a \u03b2-lactoglobulin-stabilized emulsion by very small additions of casein. Colloids Surf B Biointerfaces  2004,39(1-2),23-30","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/bip.22685","volume":"103","author":"Magee A.S.","year":"2015","unstructured":"Magee A.S.; Langeslay R.R.; Will P.M.; Danielson M.E.; Wurst L.R.; Iiams V.A.; Modification of the degree of branching of a beta-(1,3)-glucan affects aggregation behavior and activity in an oxidative burst assay. Biopolymers  2015,103(12),665-674","journal-title":"Biopolymers"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"696440","DOI":"10.3389\/fnins.2021.696440","volume":"15","author":"Szeg\u0151 \u00c9.M.","year":"2021","unstructured":"Szeg\u0151 \u00c9.M.; Bo\u00df F.; Komnig D.; G\u00e4rtner C.; H\u00f6fs L.; Shaykhalishahi H.; W\u00f6rdehoff M.M.; Saridaki T.; Schulz J.B.; Hoyer W.; Falkenburger B.H.; A \u03b2-wrapin targeting the N-terminus of \u03b1-synuclein monomers reduces fibril-induced aggregation in neurons. Front Neurosci  2021,15,696440","journal-title":"Front Neurosci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"103009","DOI":"10.1016\/j.cis.2023.103009","volume":"320","author":"Feng J.","year":"2023","unstructured":"Feng J.; She Y.; Li C.; Shen L.; Metal ion mediated aggregation of Alzheimer\u2019s disease peptides and proteins in solutions and at surfaces. Adv Colloid Interface Sci  2023,320,103009","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11596-023-2788-4","volume":"43","author":"Jia Y.","year":"2023","unstructured":"Jia Y.; Guo Z.; Guo Q.; Wang X.; Glycogen synthase kinase-3\u03b2, NLRP3 inflammasome, and Alzheimer\u2019s disease. Curr Med Sci  2023,43(5),847-854","journal-title":"Curr Med Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","volume":"351","author":"Khatoon S.","year":"1994","unstructured":"Khatoon S.; Grundke-Iqbal I.; Iqbal K.; Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett  1994,351(1),80-84","journal-title":"FEBS Lett"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","volume":"71","author":"Hanger D.P.","year":"1998","unstructured":"Hanger D.P.; Betts J.C.; Loviny T.L.F.; Blackstock W.P.; Anderton B.H.; New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer\u2019s disease brain using nanoelectrospray mass spectrometry. J Neurochem  1998,71(6),2465-2476","journal-title":"J Neurochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"114505","DOI":"10.1016\/j.expneurol.2023.114505","volume":"368","author":"Tian S.","year":"2023","unstructured":"Tian S.; Ye T.; Cheng X.; The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer\u2019s disease (3 \u00d7 Tg-AD) mouse model strain. Exp Neurol  2023,368,114505","journal-title":"Exp Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","volume":"438","author":"Chidambaram H.","year":"2020","unstructured":"Chidambaram H.; Chinnathambi S.; G-Protein Coupled receptors and tau-different roles in Alzheimer\u2019s disease. Neuroscience  2020,438,198-214","journal-title":"Neuroscience"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"983","DOI":"10.7150\/ijbs.66871","volume":"18","author":"Shen S.","year":"2022","unstructured":"Shen S.; Liao Q.; Wong Y.K.; Chen X.; Yang C.; Xu C.; Sun J.; Wang J.; The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer\u2019s disease. Int J Biol Sci  2022,18(3),983-994","journal-title":"Int J Biol Sci"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.1177\/1759091420981204","volume":"12","author":"Das R.","year":"2020","unstructured":"Das R.; Balmik A.A.; Chinnathambi S.; Melatonin reduces GSK3\u03b2-Mediated Tau Phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation. ASN Neuro  2020,12","journal-title":"ASN Neuro"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.2147\/CIA.S429440","volume":"18","author":"Hou S.J.","year":"2023","unstructured":"Hou S.J.; Zhang S.X.; Li Y.; Xu S.Y.; Rapamycin responds to alzheimer\u2019s disease: A potential translational therapy. Clin Interv Aging  2023,18,1629-1639","journal-title":"Clin Interv Aging"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.3390\/ijms21155550","volume":"21","author":"Hu C.C.","year":"2020","unstructured":"Hu C.C.; Chang C.H.; Hsiao Y.; Chang Y.; Wu Y.Y.; Ueng S.W.N.; Chen M.F.; Lipoteichoic acid accelerates bone healing by enhancing osteoblast differentiation and inhibiting osteoclast activation in a mouse model of femoral defects. Int J Mol Sci  2020,21(15),5550","journal-title":"Int J Mol Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lssr.2023.05.002","volume":"38","author":"Carvajal-Agudelo J.D.","year":"2023","unstructured":"Carvajal-Agudelo J.D.; McNeil A.; Franz-Odendaal T.A.; Effects of simulated microgravity and vibration on osteoblast and osteoclast activity in cultured zebrafish scales. Life Sci Space Res (Amst)  2023,38,39-45","journal-title":"Life Sci Space Res (Amst)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-079X.2010.00747.x","volume":"48","author":"Hoppe J.B.","year":"2010","unstructured":"Hoppe J.B.; Frozza R.L.; Horn A.P.; Comiran R.A.; Bernardi A.; Campos M.M.; Battastini A.M.O.; Salbego C.; Amyloid-\u03b2 neurotoxicity in organotypic culture is attenuated by melatonin: Involvement of GSK-3\u03b2, tau and neuroinflammation. J Pineal Res  2010,48(3),230-238","journal-title":"J Pineal Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/sj.bjc.6605839","volume":"103","author":"Hao J.","year":"2010","unstructured":"Hao J.; Chen H.; Madigan M.C.; Cozzi P.J.; Beretov J.; Xiao W.; Delprado W.J.; Russell P.J.; Li Y.; Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer  2010,103(7),1008-1018","journal-title":"Br J Cancer"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.bone.2006.06.025","volume":"39","author":"Boban I.","year":"2006","unstructured":"Boban I.; Jacquin C.; Prior K.; Barisic-Dujmovic T.; Maye P.; Clark S.H.; Aguila H.L.; The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone  2006,39(6),1302-1312","journal-title":"Bone"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.regpep.2013.12.008","volume":"189","author":"Oh Y.I.","year":"2014","unstructured":"Oh Y.I.; Kim J.H.; Kang C.W.; Protective effect of short-term treatment with parathyroid hormone 1-34 on oxidative stress is involved in insulin-like growth factor-I and nuclear factor erythroid 2-related factor 2 in rat bone marrow derived mesenchymal stem cells. Regul Pept  2014,189,1-10","journal-title":"Regul Pept"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"109431","DOI":"10.1016\/j.cellsig.2019.109431","volume":"65","author":"Xiong L.","year":"2020","unstructured":"Xiong L.; Zhong L.; Yu L.; Dan W.; Ye J.; Li J.; Liu D.; Yuan Z.; Yao J.; Zhong P.; Liu J.; Liu B.; NLS-RAR\u03b1 contributes to differentiation block and increased leukemogenic potential in vivo. Cell Signal  2020,65,109431","journal-title":"Cell Signal"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"115657","DOI":"10.1016\/j.bone.2020.115657","volume":"143","author":"Kamalakar A.","year":"2021","unstructured":"Kamalakar A.; McKinney J.M.; Salinas Duron D.; Amanso A.M.; Ballestas S.A.; Drissi H.; Willett N.J.; Bhattaram P.; Garc\u00eda A.J.; Wood L.B.; Goudy S.L.; JAGGED1 stimulates cranial neural crest cell osteoblast commitment pathways and bone regeneration independent of canonical NOTCH signaling. Bone  2021,143,115657","journal-title":"Bone"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1172\/JCI111478","volume":"74","author":"D\u2019Souza S.M.","year":"1984","unstructured":"D\u2019Souza S.M.; Ibbotson K.J.; Mundy G.R.; Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy. J Clin Invest  1984,74(3),1104-1107","journal-title":"J Clin Invest"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tox.2010.04.008","volume":"278","author":"Bonnefont-Rousselot D.","year":"2010","unstructured":"Bonnefont-Rousselot D.; Collin F.; Melatonin: Action as antioxidant and potential applications in human disease and aging. Toxicology  2010,278(1),55-67","journal-title":"Toxicology"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s11011-022-01055-9","volume":"37","author":"Maglione A.V.","year":"2022","unstructured":"Maglione A.V.; do Nascimento B.P.P.; Ribeiro M.O.; de Souza T.J.L.; da Silva R.E.C.; Sato M.A.; Penatti C.A.A.; Britto L.R.G.; de Souza J.S.; Maciel R.M.B.; da Concei\u00e7\u00e3o R.R.; Laureano-Melo R.; Giannocco G.; Triiodothyronine treatment reverses depression-like behavior in a triple-transgenic animal model of Alzheimer\u2019s disease. Metab Brain Dis  2022,37(8),2735-2750","journal-title":"Metab Brain Dis"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s12276-023-01073-2","volume":"55","author":"Kim M.Y.","year":"2023","unstructured":"Kim M.Y.; Kim M.J.; Lee C.; Lee J.; Kim S.S.; Hong S.; Kim H.T.; Seo J.; Yoon K.J.; Han S.; Trametinib activates endogenous neurogenesis and recovers neuropathology in a model of Alzheimer\u2019s disease. Exp Mol Med  2023,55(10),2177-2189","journal-title":"Exp Mol Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jamaneurol.2018.1885","volume":"75","author":"Blauwendraat C.","year":"2018","unstructured":"Blauwendraat C.; Reed X.; Kia D.A.; Gan-Or Z.; Lesage S.; Pihlstr\u00f8m L.; Guerreiro R.; Gibbs J.R.; Sabir M.; Ahmed S.; Ding J.; Alcalay R.N.; Hassin-Baer S.; Pittman A.M.; Brooks J.; Edsall C.; Hernandez D.G.; Chung S.J.; Goldwurm S.; Toft M.; Schulte C.; Bras J.; Wood N.W.; Brice A.; Morris H.R.; Scholz S.W.; Nalls M.A.; Singleton A.B.; Cookson M.R.; Frequency of loss of function variants in LRRK2 in Parkinson disease. JAMA Neurol  2018,75(11),1416-1422","journal-title":"JAMA Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1021\/bi300341j","volume":"51","author":"Wahlstr\u00f6m A.","year":"2012","unstructured":"Wahlstr\u00f6m A.; Cukalevski R.; Danielsson J.; Jarvet J.; Onagi H.; Rebek J.; Linse S.; Gr\u00e4slund A.; Specific binding of a \u03b2-cyclodextrin dimer to the amyloid \u03b2 peptide modulates the peptide aggregation process. Biochemistry  2012,51(21),4280-4289","journal-title":"Biochemistry"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neulet.2005.01.003","volume":"380","author":"Jang M.H.","year":"2005","unstructured":"Jang M.H.; Jung S.B.; Lee M.H.; Kim C.J.; Oh Y.T.; Kang I.; Kim J.; Kim E.H.; Melatonin attenuates amyloid beta25\u201335-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett  2005,380(1-2),26-31","journal-title":"Neurosci Lett"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-079X.2008.00570.x","volume":"45","author":"Zhou J.","year":"2008","unstructured":"Zhou J.; Zhang S.; Zhao X.; Wei T.; Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-\u03b2 . J Pineal Res  2008,45(2),157-165","journal-title":"J Pineal Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"100696","DOI":"10.1016\/j.jbc.2021.100696","volume":"296","author":"Cook B.","year":"2021","unstructured":"Cook B.; Walker N.; Zhang Q.; Chen S.; Evans T.; The small molecule DIPQUO promotes osteogenic differentiation via inhibition of glycogen synthase kinase 3-beta signaling. J Biol Chem  2021,296,100696","journal-title":"J Biol Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"952876","DOI":"10.3389\/fphar.2022.952876","volume":"13","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Wu X.; Yang K.; Liu Q.; Jiang B.; Yang R.; Xiao P.; He C.; Integrating network pharmacology analysis and pharmacodynamic evaluation for exploring the active components and molecular mechanism of moutan seed coat extract to improve cognitive impairment. Front Pharmacol  2022,13,952876","journal-title":"Front Pharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1042\/bst026s036","volume":"26","author":"Irvine G.B.","year":"1998","unstructured":"Irvine G.B.; El-Agnaf O.M.A.; Bodles A.M.; Guthrie D.J.S.; Harriott P.; 46 Studies on the aggregation and secondary structure of peptides derived from non-A\u03b2 component of Alzheimer\u2019s disease amyloid. Biochem Soc Trans  1998,26(1),S36","journal-title":"Biochem Soc Trans"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/ibra.12065","volume":"8","author":"Li X.Y.","year":"2022","unstructured":"Li X.Y.; Qin H.Y.; Li T.T.; Advances in the study of the relationship between Alzheimer\u2019s disease and the gastrointestinal microbiome. Ibrain  2022,8(4),465-475","journal-title":"Ibrain"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1523\/JNEUROSCI.5175-08.2009","volume":"29","author":"Ho C.C.Y.","year":"2009","unstructured":"Ho C.C.Y.; Rideout H.J.; Ribe E.; Troy C.M.; Dauer W.T.; The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci  2009,29(4),1011-1016","journal-title":"J Neurosci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainres.2005.03.053","volume":"1046","author":"Nam E.","year":"2005","unstructured":"Nam E.; Lee S.M.; Koh S.E.; Joo W.S.; Maeng S.; Im H.I.; Kim Y.S.; Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res  2005,1046(1-2),90-96","journal-title":"Brain Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/1567205017666200810164932","volume":"17","author":"Zhu Y.","year":"2020","unstructured":"Zhu Y.; Ding X.; She Z.; Bai X.; Nie Z.; Wang F.; Wang F.; Geng X.; Exploring shared pathogenesis of Alzheimer\u2019s disease and type 2 diabetes mellitus via co-expression networks analysis. Curr Alzheimer Res  2020,17(6),566-575","journal-title":"Curr Alzheimer Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuro.2023.11.006","volume":"99","author":"Komlao P.","year":"2023","unstructured":"Komlao P.; Kraiwattanapirom N.; Promyo K.; Hein Z.M.; Chetsawang B.; Melatonin enhances the restoration of neurological impairments and cognitive deficits during drug withdrawal in methamphetamine-induced toxicity and endoplasmic reticulum stress in rats. Neurotoxicology  2023,99,305-312","journal-title":"Neurotoxicology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4149\/BLL_2013_028","volume":"114","author":"Butun I.","year":"2013","unstructured":"Butun I.; Ekmekci H.; Ciftci O.; Sonmez H.; Caner M.; Altug T.; Kokoglu E.; The effects of different doses of melatonin on lipid peroxidation in diet-induced hypercholesterolemic rats. Bratisl Med J  2013,114(3),129-132","journal-title":"Bratisl Med J"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.phrs.2016.09.010","volume":"113","author":"Villa V","year":"2016","unstructured":"Villa V; Thellung S; Bajetto A; Gatta E; Robello M; Novelli F; Tasso B; Tonelli M; Florio T.; Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide. Pharmacol Res  2016,113,500-514","journal-title":"Pharmacol Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1021\/bi990205o","volume":"38","author":"Liu S.T.","year":"1999","unstructured":"Liu S.T.; Howlett G.; Barrow C.J.; Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer\u2019s disease. Biochemistry  1999,38(29),9373-9378","journal-title":"Biochemistry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3233\/JAD-2003-5607","volume":"5","author":"Woltjer R.L.","year":"2004","unstructured":"Woltjer R.L.; Maezawa I.; Ou J.J.; Montine K.S.; Montine T.J.; Advanced glycation endproduct precursor alters intracellular amyloid- \u03b2\/A\u03b2PP carboxy-terminal fragment aggregation and cytotoxicity. J Alzheimers Dis  2004,5(6),467-476","journal-title":"J Alzheimers Dis"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"21990","DOI":"10.1073\/pnas.1006091107","volume":"107","author":"Choi J.S.","year":"2010","unstructured":"Choi J.S.; Braymer J.J.; Nanga R.P.R.; Ramamoorthy A.; Lim M.H.; Design of small molecules that target metal-A\u03b2 species and regulate metal-induced A\u03b2 aggregation and neurotoxicity. Proc Natl Acad Sci USA  2010,107(51),21990-21995","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/biomedicines9050466","volume":"9","author":"Caruso G.I.","year":"2021","unstructured":"Caruso G.I.; Spampinato S.F.; Costantino G.; Merlo S.; Sortino M.A.; SIRT1-dependent upregulation of BDNF in human microglia challenged with A\u03b2: An early but transient response rescued by melatonin. Biomedicines  2021,9(5),466","journal-title":"Biomedicines"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2008.09.017","volume":"46","author":"Luchetti F.","year":"2009","unstructured":"Luchetti F.; Betti M.; Canonico B.; Arcangeletti M.; Ferri P.; Galli F.; Papa S.; ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic Biol Med  2009,46(3),339-351","journal-title":"Free Radic Biol Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/brain.2022.0058","volume":"13","author":"Crook H.","year":"2023","unstructured":"Crook H.; Ramirez A.; Hosseini A.; Vavougyios G.; Lehmann C.; Bruchfeld J.; Schneider A.; D\u2019Avossa G.; Lo Re V.; Salmoiraghi A.; Mukaetova-Ladinska E.; Katshu M.; Boneschi F.M.; H\u00e5kansson K.; Geerlings M.; Pracht E.; Ruiz A.; Jansen J.F.A.; Snyder H.; Kivipelto M.; Edison P.; European working group on SARS-CoV-2: Current understanding, unknowns, and recommendations on the neurological complications of COVID-19. Brain Connect  2023,13(4),178-210","journal-title":"Brain Connect"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1021\/bi002186k","volume":"40","author":"Koldamova R.P.","year":"2001","unstructured":"Koldamova R.P.; Lefterov I.M.; Lefterova M.I.; Lazo J.S.; Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity. Biochemistry  2001,40(12),3553-3560","journal-title":"Biochemistry"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.health.2022.100114","volume":"2","author":"Addai E.","year":"2022","unstructured":"Addai E.; Zhang L.; Preko A.K.; Asamoah J.K.K.; Fractional order epidemiological model of SARS-CoV-2 dynamism involving Alzheimer\u2019s disease. Healthcare Analytics  2022,2,100114","journal-title":"Healthcare Analytics"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/jpi.12182","volume":"57","author":"Jeong J.K.","year":"2014","unstructured":"Jeong J.K.; Lee J.H.; Moon J.H.; Lee Y.J.; Park S.Y.; Melatonin-mediated \u03b2 -catenin activation protects neuron cells against prion protein-induced neurotoxicity. J Pineal Res  2014,57(4),427-434","journal-title":"J Pineal Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s43587-022-00241-9","volume":"2","author":"Jiang Y.","year":"2022","unstructured":"Jiang Y.; Zhou X.; Wong H.Y.; Ouyang L.; Ip F.C.F.; Chau V.M.N.; Lau S.F.; Wu W.; Wong D.Y.K.; Seo H.; Fu W.Y.; Lai N.C.H.; Chen Y.; Chen Y.; Tong E.P.S.; Weiner M.W.; Aisen P.; Petersen R.; Jack C.R.; Jagust W.; Trojanowski J.Q.; Toga A.W.; Beckett L.; Green R.C.; Saykin A.J.; Morris J.; Shaw L.M.; Khachaturian Z.; Sorensen G.; Kuller L.; Raichle M.; Paul S.; Davies P.; Fillit H.; Hefti F.; Holtzman D.; Mesulam M.M.; Potter W.; Snyder P.; Schwartz A.; Montine T.; Thomas R.G.; Donohue M.; Walter S.; Gessert D.; Sather T.; Jiminez G.; Harvey D.; Bernstein M.; Thompson P.; Schuff N.; Borowski B.; Gunter J.; Senjem M.; Vemuri P.; Jones D.; Kantarci K.; Ward C.; Koeppe R.A.; Foster N.; Reiman E.M.; Chen K.; Mathis C.; Landau S.; Cairns N.J.; Householder E.; Taylor-Reinwald L.; Lee V.; Korecka M.; Figurski M.; Crawford K.; Neu S.; Foroud T.M.; Potkin S.G.; Shen L.; Faber K.; Kim S.; Nho K.; Thal L.; Buckholtz N.; Albert M.; Frank R.; Hsiao J.; Kaye J.; Quinn J.; Lind B.; Carter R.; Dolen S.; Schneider L.S.; Pawluczyk S.; Beccera M.; Teodoro L.; Spann B.M.; Brewer J.; Vanderswag H.; Fleisher A.; Heidebrink J.L.; Lord J.L.; Mason S.S.; Albers C.S.; Knopman D.; Johnson K.; Doody R.S.; Villanueva-Meyer J.; Chowdhury M.; Rountree S.; Dang M.; Stern Y.; Honig L.S.; Bell K.L.; Ances B.; Carroll M.; Leon S.; Mintun M.A.; Schneider S.; Oliver A.; Marson D.; Griffith R.; Clark D.; Geldmacher D.; Brockington J.; Roberson E.; Grossman H.; Mitsis E.; de Toledo-Morrell L.; Shah R.C.; Duara R.; Varon D.; Greig M.T.; Roberts P.; Onyike C.; D\u2019Agostino D.; Kielb S.; Galvin J.E.; Cerbone B.; Michel C.A.; Rusinek H.; de Leon M.J.; Glodzik L.; De Santi S.; Doraiswamy P.M.; Petrella J.R.; Wong T.Z.; Arnold S.E.; Karlawish J.H.; Wolk D.; Smith C.D.; Jicha G.; Hardy P.; Sinha P.; Oates E.; Conrad G.; Lopez O.L.; Oakley M.A.; Simpson D.M.; Porsteinsson A.P.; Goldstein B.S.; Martin K.; Makino K.M.; Ismail M.S.; Brand C.; Mulnard R.A.; Thai G.; McAdams-Ortiz C.; Womack K.; Mathews D.; Quiceno M.; Diaz-Arrastia R.; King R.; Weiner M.; Martin-Cook K.; DeVous M.; Levey A.I.; Lah J.J.; Cellar J.S.; Burns J.M.; Anderson H.S.; Swerdlow R.H.; Apostolova L.; Tingus K.; Woo E.; Silverman D.H.S.; Lu P.H.; Bartzokis G.; Graff-Radford N.R.; Parfitt F.; Kendall T.; Johnson H.; Farlow M.R.; Hake A.M.; Matthews B.R.; Herring S.; Hunt C.; van Dyck C.H.; Carson R.E.; MacAvoy M.G.; Chertkow H.; Bergman H.; Hosein C.; Hsiung G-Y.R.; Feldman H.; Mudge B.; Assaly M.; Bernick C.; Munic D.; Kertesz A.; Rogers J.; Trost D.; Kerwin D.; Lipowski K.; Wu C-K.; Johnson N.; Sadowsky C.; Martinez W.; Villena T.; Turner R.S.; Johnson K.; Reynolds B.; Sperling R.A.; Johnson K.A.; Marshall G.; Frey M.; Lane B.; Rosen A.; Tinklenberg J.; Sabbagh M.N.; Belden C.M.; Jacobson S.A.; Sirrel S.A.; Kowall N.; Killiany R.; Budson A.E.; Norbash A.; Johnson P.L.; Allard J.; Lerner A.; Ogrocki P.; Hudson L.; Fletcher E.; Carmichael O.; Olichney J.; DeCarli C.; Kittur S.; Borrie M.; Lee T-Y.; Bartha R.; Johnson S.; Asthana S.; Carlsson C.M.; Preda A.; Nguyen D.; Tariot P.; Reeder S.; Bates V.; Capote H.; Rainka M.; Scharre D.W.; Kataki M.; Adeli A.; Zimmerman E.A.; Celmins D.; Brown A.D.; Pearlson G.D.; Blank K.; Anderson K.; Santulli R.B.; Kitzmiller T.J.; Schwartz E.S.; Sink K.M.; Williamson J.D.; Garg P.; Watkins F.; Ott B.R.; Querfurth H.; Tremont G.; Salloway S.; Malloy P.; Correia S.; Rosen H.J.; Miller B.L.; Mintzer J.; Spicer K.; Bachman D.; Pasternak S.; Rachinsky I.; Drost D.; Pomara N.; Hernando R.; Sarrael A.; Schultz S.K.; Ponto L.L.B.; Shim H.; Smith K.E.; Relkin N.; Chaing G.; Raudin L.; Smith A.; Fargher K.; Raj B.A.; Neylan T.; Grafman J.; Davis M.; Morrison R.; Hayes J.; Finley S.; Friedl K.; Fleischman D.; Arfanakis K.; James O.; Massoglia D.; Fruehling J.J.; Harding S.; Peskind E.R.; Petrie E.C.; Li G.; Yesavage J.A.; Taylor J.L.; Furst A.J.; Mok V.C.T.; Kwok T.C.Y.; Mok K.Y.; Shoai M.; Lehallier B.; Losada P.M.; O\u2019Brien E.; Porter T.; Laws S.M.; Hardy J.; Wyss-Coray T.; Masters C.L.; Fu A.K.Y.; Ip N.Y.; An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-\u03b54 in female patients with Alzheimer\u2019s disease. Nature Aging  2022,2(7),616-634","journal-title":"Nature Aging"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"102072","DOI":"10.1016\/j.arr.2023.102072","volume":"91","author":"Shanmugavadivel K.","year":"2023","unstructured":"Shanmugavadivel K.; Sathishkumar V.E.; Cho J.; Subramanian M.; Advancements in computer-assisted diagnosis of Alzheimer\u2019s disease: A comprehensive survey of neuroimaging methods and AI techniques for early detection. Ageing Res Rev  2023,91,102072","journal-title":"Ageing Res Rev"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"12411","DOI":"10.3390\/ijms241512411","volume":"24","author":"G\u00e9raudie A.","year":"2023","unstructured":"G\u00e9raudie A.; Riche M.; Lestra T.; Trotier A.; Dupuis L.; Mathon B.; Carpentier A.; Delatour B.; Effects of low-intensity pulsed ultrasound-induced blood\u2013brain barrier opening in P301S mice modeling Alzheimer\u2019s disease tauopathies. Int J Mol Sci  2023,24(15),12411","journal-title":"Int J Mol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-079X.2004.00196.x","volume":"38","author":"Wu Y.H.","year":"2005","unstructured":"Wu Y.H.; Swaab D.F.; The human pineal gland and melatonin in aging and Alzheimer\u2019s disease. J Pineal Res  2005,38(3),145-152","journal-title":"J Pineal Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1034\/j.1600-079X.2003.00065.x","volume":"35","author":"Zhou J.N.","year":"2003","unstructured":"Zhou J.N.; Liu R.Y.; Kamphorst W.; Hofman M.A.; Swaab D.F.; Early neuropathological Alzheimer\u2019s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res  2003,35(2),125-130","journal-title":"J Pineal Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1567205011666140220125324","volume":"11","author":"Zhang Y.H.","year":"2014","unstructured":"Zhang Y.H.; Mann D.; Raymick J.; Sarkar S.; Paule M.; Lahiri D.; Dumas M.; Cohen A.B.; Schmued L.; K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD\/Tg mice. Curr Alzheimer Res  2014,11(3),299-308","journal-title":"Curr Alzheimer Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"13331","DOI":"10.3390\/ijms232113331","volume":"23","author":"Yang Y.","year":"2022","unstructured":"Yang Y.; Bagyinszky E.; An S.S.A.; Kim S.; PSEN2 Thr421Met mutation in a patient with early onset Alzheimer\u2019s disease. Int J Mol Sci  2022,23(21),13331","journal-title":"Int J Mol Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neurol.2020.06.009","volume":"177","author":"Vecchierini M.F.","year":"2021","unstructured":"Vecchierini M.F.; Kilic-Huck U.; Quera-Salva M.A.; Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). Rev Neurol (Paris)  2021,177(3),245-259","journal-title":"Rev Neurol (Paris)"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1081\/CBI-100101055","volume":"17","author":"Mishima K.","year":"2000","unstructured":"Mishima K.; Okawa M.; Hozumi S.; Hishikawa Y.; Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol Int  2000,17(3),419-432","journal-title":"Chronobiol Int"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","volume":"56","author":"Dowling G.A.","year":"2008","unstructured":"Dowling G.A.; Burr R.L.; Van Someren E.J.W.; Hubbard E.M.; Luxenberg J.S.; Mastick J.; Cooper B.A.; Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer\u2019s disease. J Am Geriatr Soc  2008,56(2),239-246","journal-title":"J Am Geriatr Soc"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1600-079X.2007.00491.x","volume":"43","author":"Furio A.M.","year":"2007","unstructured":"Furio A.M.; Brusco L.I.; Cardinali D.P.; Possible therapeutic value of melatonin in mild cognitive impairment: A retrospective study. J Pineal Res  2007,43(4),404-409","journal-title":"J Pineal Res"},{"key":"ref=109","first-page":"280","volume":"1","author":"Cardinali D.P.","year":"2012","unstructured":"Cardinali D.P.; Vigo D.E.; Olivar N.; Vidal M.F.; Furio A.M.; Brusco L.I.; Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis  2012,1(3),280-291","journal-title":"Am J Neurodegener Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3233\/ADR-170019","volume":"2","author":"Cruz-Aguilar M.A.","year":"2018","unstructured":"Cruz-Aguilar M.A.; Ram\u00edrez-Salado I.; Guevara M.A.; Hern\u00e1ndez-Gonz\u00e1lez M.; Benitez-King G.; Melatonin effects on EEG activity during sleep onset in mild-to-moderate Alzheimer\u2019s disease: A pilot study. J Alzheimers Dis Rep  2018,2(1),55-65","journal-title":"J Alzheimers Dis Rep"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000435889","volume":"96","author":"Yin Y.","year":"2015","unstructured":"Yin Y.; Liu Y.; Zhuang J.; Pan X.; Li P.; Yang Y.; Li Y.P.; Zhao Z.Q.; Huang L.Q.; Zhao Z.X.; Low-dose atypical antipsychotic risperidone improves the 5-Year outcome in Alzheimer\u2019s disease patients with sleep disturbances. Pharmacology  2015,96(3-4),155-162","journal-title":"Pharmacology"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1038\/s41467-023-40546-w","volume":"14","author":"Warfield A.E.","year":"2023","unstructured":"Warfield A.E.; Gupta P.; Ruhmann M.M.; Jeffs Q.L.; Guidone G.C.; Rhymes H.W.; Thompson M.I.; Todd W.D.; A brainstem to circadian system circuit links Tau pathology to sundowning-related disturbances in an Alzheimer\u2019s disease mouse model. Nat Commun  2023,14(1),5027","journal-title":"Nat Commun"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/jgs.12296","volume":"61","author":"Lammers M.","year":"2013","unstructured":"Lammers M.; Ahmed A.I.A.; Melatonin for sundown syndrome and delirium in dementia: Is it effective? J Am Geriatr Soc  2013,61(6),1045-1046","journal-title":"J Am Geriatr Soc"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000014580","volume":"8","author":"Brusco L.","year":"1999","unstructured":"Brusco L.; Fainstein I.; M\u00e1rquez M.; Cardinali D.; Effect of melatonin in selected populations of sleep-disturbed patients. Neurosignals  1999,8(1-2),126-131","journal-title":"Neurosignals"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43587-022-00310-z","volume":"2","author":"Pereira J.B.","year":"2022","unstructured":"Pereira J.B.; Janelidze S.; Strandberg O.; Whelan C.D.; Zetterberg H.; Blennow K.; Palmqvist S.; Stomrud E.; Mattsson-Carlgren N.; Hansson O.; Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer\u2019s disease pathology. Nature Aging  2022,2(12),1138-1144","journal-title":"Nature Aging"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3233\/JAD-215059","volume":"86","author":"Alves S.R.","year":"2022","unstructured":"Alves S.R.; da Cruz e Silva C.; Rosa I.M.; Henriques A.G.; da Cruz e Silva O.A.B.; A bioinformatics approach toward unravelling the synaptic molecular crosstalk between Alzheimer\u2019s disease and diabetes. J Alzheimers Dis  2022,86(4),1917-1933","journal-title":"J Alzheimers Dis"},{"key":"ref=117","first-page":"947","volume":"9","author":"Wade A.G.","year":"2014","unstructured":"Wade A.G.; Farmer M.; Harari G.; Fund N.; Laudon M.; Nir T.; Frydman-Marom A.; Zisapel N.; Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer\u2019s disease: A 6-month, randomized, placebo-controlled, multicenter trial. Clin Interv Aging  2014,9,947-961","journal-title":"Clin Interv Aging"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673286807240326085736","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228440\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673286807240326085736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:47:04Z","timestamp":1758001624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228440\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":117,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673286807240326085736","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}